Gilead's remdesivir gets U.S. FDA approval
Video Credit: Reuters Studio - Duration: 01:29s - Published
Gilead's remdesivir gets U.S. FDA approval
The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.
Gavino Garay reports.